clinical experience of using biological hepatoprotector prohepar in the treatment of patients with hepatobiliary pathology (review)
Clicks: 159
ID: 217869
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
159 views
39 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #27 of 28 articles by views in micro and nano systems letters
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The article provides an overview of researches to assess the efficacy and safety of using biological hepatoprotector Prohepar in patients with chronic diffuse liver diseases. Used regimens contribute to the normalization of liver function tests, improve general condition of the patient, in particular a decrease in the manifestations of asthenic syndrome.
| Reference Key |
stepanov2015gastroenterologaclinical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Yu.M. Stepanov;Yu.S. Breslavets |
| Journal | micro and nano systems letters |
| Year | 2015 |
| DOI |
10.22141/2308-2097.3.57.2015.81536
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.